Cargando…

Identification and Evaluation of Autoantibody to a Novel Tumor-Associated Antigen GNA11 as a Biomarker in Esophageal Squamous Cell Carcinoma

The study aims to explore the diagnostic value of anti-GNA11 autoantibody in esophageal squamous cell carcinoma (ESCC) from multiple levels. Autoantibody against GNA11 with the highest diagnostic performance was screened out from the customized protein microarray. A total of 486 subjects including E...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Huimin, Yang, Xiaoang, Sun, Guiying, Yang, Qian, Cui, Chi, Wang, Xiao, Ye, Hua, Dai, Liping, Shi, Jianxiang, Zhang, Jianying, Wang, Peng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8462091/ https://www.ncbi.nlm.nih.gov/pubmed/34568004 http://dx.doi.org/10.3389/fonc.2021.661043

Ejemplares similares

Autoantibodies against tumor‐associated antigens combined with microRNAs in detecting esophageal squamous cell carcinoma
por: Sun, Guiying, et al.
Publicado: (2019)

Serum anti-SPP1 autoantibody as a potential novel biomarker in detection of esophageal squamous cell carcinoma
por: Wang, Chen, et al.
Publicado: (2022)

Identification of Novel Autoantibodies Based on the Human Proteomic Chips and Evaluation of Their Performance in the Detection of Gastric Cancer
por: Cui, Chi, et al.
Publicado: (2021)

Identification of novel autoantibodies based on the protein chip encoded by cancer-driving genes in detection of esophageal squamous cell carcinoma
por: Sun, Guiying, et al.
Publicado: (2020)

Anti-CXCL8 Autoantibody: A Potential Diagnostic Biomarker for Esophageal Squamous Cell Carcinoma
por: Chen, Huili, et al.
Publicado: (2022)

Autoantibodies to PAX5, PTCH1, and GNA11 as Serological Biomarkers in the Detection of Hepatocellular Carcinoma in Hispanic Americans
por: Qiu, Cuipeng, et al.
Publicado: (2023)

Human Proteome Microarray identifies autoantibodies to tumor‐associated antigens as serological biomarkers for the diagnosis of hepatocellular carcinoma
por: Yang, Qian, et al.
Publicado: (2023)

Identification of novel autoantibody signatures and evaluation of a panel of autoantibodies in breast cancer
por: Qiu, Cuipeng, et al.
Publicado: (2021)

Serological Biomarkers for Early Detection of Hepatocellular Carcinoma: A Focus on Autoantibodies against Tumor-Associated Antigens Encoded by Cancer Driver Genes
por: Wang, Keyan, et al.
Publicado: (2020)

Anti-POSTN and Anti-TIMP1 Autoantibodies as Diagnostic Markers in Esophageal Squamous Cell Carcinoma
por: Xie, Weihong, et al.
Publicado: (2022)

Using protein microarray to identify and evaluate autoantibodies to tumor‐associated antigens in ovarian cancer
por: Ma, Yan, et al.
Publicado: (2020)

Serum Autoantibodies against LRDD, STC1, and FOXA1 as Biomarkers in the Detection of Ovarian Cancer
por: Duan, Yaru, et al.
Publicado: (2022)

A novel immunodiagnosis panel for hepatocellular carcinoma based on bioinformatics and the autoantibody‐antigen system
por: Wu, Jinyu, et al.
Publicado: (2021)

Lack of GNAQ and GNA11 Germ-Line Mutations in Familial Melanoma Pedigrees with Uveal Melanoma or Blue Nevi
por: Hawkes, Jason E., et al.
Publicado: (2013)

Discovery and Validation of Serum Autoantibodies Against Tumor-Associated Antigens as Biomarkers in Gastric Adenocarcinoma Based on the Focused Protein Arrays
por: Yang, Qian, et al.
Publicado: (2020)

GNA14, GNA11, and GNAQ Mutations Are Frequent in Benign but Not Malignant Cutaneous Vascular Tumors
por: Jansen, Philipp, et al.
Publicado: (2021)

Editorial: Tumor-associated antigens and their autoantibodies, from discovering to clinical utilization
por: Zhang, Jianying, et al.
Publicado: (2022)

Postoperative serum squamous cell carcinoma antigen and carcinoembryonic antigen predict overall survival in surgical patients with esophageal squamous cell carcinoma
por: Huang, Yi, et al.
Publicado: (2023)

Identification of novel serum autoantibody biomarkers for early esophageal squamous cell carcinoma and high-grade intraepithelial neoplasia detection
por: Chen, Zhibin, et al.
Publicado: (2023)

Gnaq and Gna11 in the Endothelin Signaling Pathway and Melanoma
por: Urtatiz, Oscar, et al.
Publicado: (2016)

Downregulation of GNA15 Inhibits Cell Proliferation via P38 MAPK Pathway and Correlates with Prognosis of Adult Acute Myeloid Leukemia With Normal Karyotype
por: Li, Mengya, et al.
Publicado: (2021)

GNA11 brain somatic pathogenic variant in an individual with phacomatosis pigmentovascularis
por: Sliepka, Joseph M., et al.
Publicado: (2019)

Oncogenic GNAQ and GNA11 Mutations in Uveal Melanoma in Chinese
por: Xu, Xiaolin, et al.
Publicado: (2014)

Mutation spectrum in GNAQ and GNA11 in Chinese uveal melanoma
por: Zhang, Edward D, et al.
Publicado: (2019)

Heterogeneity in Mitogen-Activated Protein Kinase (MAPK) Pathway Activation in Uveal Melanoma With Somatic GNAQ and GNA11 Mutations
por: Boru, Getachew, et al.
Publicado: (2019)

Peroxiredoxin 1 is a tumor-associated antigen in esophageal squamous cell carcinoma
por: REN, PENGFEI, et al.
Publicado: (2013)

Serum Anti-PDLIM1 Autoantibody as Diagnostic Marker in Ovarian Cancer
por: Qiu, Cuipeng, et al.
Publicado: (2021)

GNAQ and GNA11 mutations and downstream YAP activation in choroidal nevi
por: Vader, M J C, et al.
Publicado: (2017)

Identification of Immune-Cell-Related Prognostic Biomarkers of Esophageal Squamous Cell Carcinoma Based on Tumor Microenvironment
por: Cui, Yiyao, et al.
Publicado: (2021)

A hybrid GNA instability
por: Karmakar, Pralay Kumar, et al.
Publicado: (2022)

Involvement of Glutathione Depletion in Selective Cytotoxicity of Oridonin to p53-Mutant Esophageal Squamous Carcinoma Cells
por: Li, Yinchao, et al.
Publicado: (2020)

Patient survival in uveal melanoma is not affected by oncogenic mutations in GNAQ and GNA11
por: Koopmans, A E, et al.
Publicado: (2013)

YAP inhibition blocks uveal melanogenesis driven by GNAQ or GNA11 mutations
por: Lyubasyuk, Vera, et al.
Publicado: (2014)

Autoantibodies as Potential Biomarkers for the Early Detection of Esophageal Squamous Cell Carcinoma
por: Xu, Yi-Wei, et al.
Publicado: (2014)

Serum Metabolomic Profiling Reveals Biomarkers for Early Detection and Prognosis of Esophageal Squamous Cell Carcinoma
por: Wang, Pan Pan, et al.
Publicado: (2022)

Predicting the efficacy of radiotherapy for esophageal squamous cell carcinoma based on enhanced computed tomography radiomics and combined models
por: Liu, Jihui, et al.
Publicado: (2023)

A Nomogram for Predicting Lymphovascular Invasion in Superficial Esophageal Squamous Cell Carcinoma
por: Ruan, Rongwei, et al.
Publicado: (2021)

Development of a salivary autoantibody biomarker panel for diagnosis of oral cavity squamous cell carcinoma
por: Hsueh, Pei-Chun, et al.
Publicado: (2022)

Relationship Between PTEN and Angiogenesis of Esophageal Squamous Cell Carcinoma and the Underlying Mechanism
por: Yang, Chenbo, et al.
Publicado: (2021)

GNA13 expression promotes drug resistance and tumor-initiating phenotypes in squamous cell cancers
por: Rasheed, Suhail Ahmed Kabeer, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_1nubm3o121bob06lamklajh02q